News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
400,512 Results
Type
Article (26586)
Company Profile (71)
Press Release (373855)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (111874)
Career Advice (468)
Deals (18627)
Drug Delivery (52)
Drug Development (49010)
Employer Resources (50)
FDA (12601)
Job Trends (8897)
News (197095)
Policy (20320)
Tag
Academia (1787)
Academic (1)
Accelerated approval (3)
Adcomms (8)
Allergies (76)
Alliances (27542)
ALS (61)
Alzheimer's disease (826)
Antibody-drug conjugate (ADC) (58)
Approvals (12660)
Artificial intelligence (173)
Autoimmune disease (10)
Automation (4)
Bankruptcy (146)
Best Places to Work (7254)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (44)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (211)
Cancer (1501)
Cardiovascular disease (127)
Career advice (423)
Career pathing (13)
CAR-T (73)
Cell therapy (211)
Cervical cancer (15)
Clinical research (41750)
Collaboration (463)
Compensation (140)
Complete response letters (12)
COVID-19 (1529)
CRISPR (14)
C-suite (150)
Cystic fibrosis (45)
Data (1632)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (182)
Diagnostics (3835)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (55)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (58)
Earnings (43269)
Editorial (22)
Employer branding (7)
Employer resources (45)
Events (53701)
Executive appointments (462)
FDA (13686)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (416)
Gene editing (44)
Generative AI (10)
Gene therapy (133)
GLP-1 (424)
Government (3112)
Grass and pollen (3)
Guidances (116)
Healthcare (12726)
Huntington's disease (10)
IgA nephropathy (17)
Immunology and inflammation (45)
Indications (20)
Infectious disease (1605)
Inflammatory bowel disease (84)
Inflation Reduction Act (4)
Influenza (28)
Intellectual property (51)
Interviews (44)
IPO (8381)
IRA (19)
Job creations (1942)
Job search strategy (394)
Kidney cancer (7)
Labor market (14)
Layoffs (193)
Leadership (4)
Legal (3873)
Liver cancer (57)
Lung cancer (239)
Lymphoma (102)
Machine learning (4)
Management (17)
Manufacturing (120)
MASH (53)
Medical device (13175)
Medtech (13178)
Mergers & acquisitions (10588)
Metabolic disorders (451)
Multiple sclerosis (58)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1177)
NextGen: Class of 2025 (4109)
Non-profit (2953)
Now hiring (19)
Obesity (224)
Opinion (84)
Ovarian cancer (56)
Pain (67)
Pancreatic cancer (58)
Parkinson's disease (92)
Partnered (11)
Patents (122)
Patient recruitment (84)
Peanut (37)
People (35365)
Pharmaceutical (19)
Pharmacy benefit managers (12)
Phase I (11947)
Phase II (18112)
Phase III (14825)
Pipeline (838)
Policy (63)
Postmarket research (1719)
Preclinical (3756)
Press Release (20)
Prostate cancer (80)
Psychedelics (17)
Radiopharmaceuticals (164)
Rare diseases (193)
Real estate (3025)
Recruiting (17)
Regulatory (14853)
Reports (18)
Research institute (1648)
Resumes & cover letters (51)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (54)
Series A (67)
Series B (50)
Service/supplier (5)
Sickle cell disease (23)
Special edition (4)
Spinal muscular atrophy (107)
Sponsored (13)
Startups (2159)
Stomach cancer (8)
Supply chain (40)
Tariffs (14)
The Weekly (8)
Vaccines (368)
Venture capitalists (13)
Weight loss (142)
Women's health (18)
Worklife (4)
Date
Today (92)
Last 7 days (517)
Last 30 days (1711)
Last 365 days (19217)
2025 (6720)
2024 (20926)
2023 (23960)
2022 (31932)
2021 (34610)
2020 (33709)
2019 (29555)
2018 (22731)
2017 (21062)
2016 (18680)
2015 (21841)
2014 (16500)
2013 (13646)
2012 (14763)
2011 (15155)
2010 (13694)
Location
Africa (368)
Alabama (18)
Alaska (3)
Arizona (125)
Arkansas (10)
Asia (25641)
Australia (3993)
California (3377)
Canada (1280)
China (389)
Colorado (171)
Connecticut (181)
Delaware (125)
Europe (50120)
Florida (598)
Georgia (138)
Idaho (34)
Illinois (374)
India (16)
Indiana (237)
Iowa (3)
Japan (126)
Kansas (79)
Kentucky (13)
Louisiana (9)
Maine (29)
Maryland (662)
Massachusetts (2311)
Michigan (119)
Minnesota (305)
Mississippi (2)
Missouri (53)
Montana (18)
Nebraska (19)
Nevada (37)
New Hampshire (60)
New Jersey (1208)
New Mexico (10)
New York (1036)
North Carolina (586)
North Dakota (5)
Northern California (1499)
Ohio (137)
Oklahoma (3)
Oregon (23)
Pennsylvania (909)
Puerto Rico (7)
Rhode Island (24)
South America (543)
South Carolina (23)
Southern California (1279)
Tennessee (80)
Texas (590)
United States (13862)
Utah (119)
Virginia (88)
Washington D.C. (45)
Washington State (251)
West Virginia (3)
Wisconsin (45)
400,512 Results for "180 medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
180 Life Sciences Corp. Announces Share Repurchase
April 30, 2025
·
7 min read
Press Releases
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
May 1, 2025
·
7 min read
Press Releases
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
January 15, 2025
·
4 min read
Press Releases
Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
January 17, 2025
·
5 min read
Press Releases
Timberlyne Therapeutics Launches with a $180 Million Series A Financing to Advance CM313, a Potentially Best-in-Class Anti-CD38 Monoclonal Antibody, for Diseases of High Unmet Medical Needs
January 10, 2025
·
4 min read
Press Releases
Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants
December 18, 2024
·
5 min read
Press Releases
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
January 2, 2025
·
5 min read
Press Releases
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
December 5, 2024
·
8 min read
Press Releases
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
December 23, 2024
·
3 min read
Press Releases
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
December 12, 2024
·
8 min read
1 of 40,052
Next
